Common leukemia- and lymphoma-associated genetic aberrations in healthy individuals

Journal of Molecular Diagnostics

Volumn 13, Issue 2, 2011, Pages 213-219

  Song, Jianbo ^a   Mercer, Danielle ^a   Hu, Xiaofeng ^a   Liu, Henry ^a   Li, Marilyn M ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AF4 PROTEIN; BCR ABL PROTEIN; CBFB PROTEIN; ETO PROTEIN; MIXED LINEAGE LEUKEMIA PROTEIN; MYH11 PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN; PROTEIN P190; RARA PROTEIN; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGAR GEL ELECTROPHORESIS; ARTICLE; CHILD; CHROMOSOME ABERRATION; CHROMOSOME REARRANGEMENT; COHORT ANALYSIS; CONTROLLED STUDY; GENE DUPLICATION; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; LEUKEMIA AND LYMPHOMA CHROMOSOME; NEWBORN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; UMBILICAL CORD;

EID: 79952253654     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2010.10.009     Document Type: Article

References (30)

1. Rowley JD: The role of chromosome translocations in leukemogenesis. Semin Hematol 1999, 36:59-72
2. Janz S, Potter M, Rabkin CS: Lymphoma- and leukemia-associated chromosomal translocations in healthy individuals. Genes Chromosomes Cancer 2003, 36:211-223 (Pubitemid 36158194)
3. Kaneko Y, Maseki N, Takasaki N, Sakurai M, Hayashi Y, Nakazawa S, Mori T, Sakurai M, Takada T, Shikano T, Hiyoshi Y: Clinical and hematologic characteristics in acute leukemia with 11q23 translocations. Blood 1986, 67:484-491 (Pubitemid 16164669)
4. Caligiuri MA, Schichman SA, Strout MP, Mrozek K, Baer MR, Frankel SR, Barcos M, Herzig GP, Croce CM, Bloomfield CD: Molecular rearrangement of the ALL-1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocations. Cancer Res 1994, 54:370-373 (Pubitemid 24053170)
5. Schichman SA, Caligiuri MA, Gu Y, Strout MP, Canaani E, Bloomfield CD, Croce CM: ALL-1 partial duplication in acute leukemia. Proc Natl Acad Sci USA 1994, 91:6236-6239 (Pubitemid 24188318)
6. Basecke J, Podleschny M, Clemens R, Schnittger S, Viereck V, Trumper L, Griesinger F: Lifelong persistence of AML associated MLL partial tandem duplications (MLL-PTD) in healthy adults. Leuk Res 2006, 30:1091-1096 (Pubitemid 44037091)
7. Schlenk RF, Dohner K, Krauter J, Frohling S, Corbacioglu A, Bullinger L, Habdank M, Späth D, Morgan M, Benner A, Schlegelberger B, Heil G, Ganser A, Döhner H: Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med 2008, 358:1909-1918 (Pubitemid 351620111)
8. Schnittger S, Wormann B, Hiddemann W, Griesinger F: Partial tandem duplications of the MLL gene are detectable in peripheral blood and bone marrow of nearly all healthy donors. Blood 1998, 92:1728-1734 (Pubitemid 28406878)
9. Heisterkamp N, Groffen J: Molecular insights into the Philadelphia translocation. Hematol Pathol 1991, 5:1-10
10. Pakakasama S, Kajanachumpol S, Kanjanapongkul S, Sirachainan N, Meekaewkunchorn A, Ningsanond V, Hongeng S: Simple multiplex RT-PCR for identifying common fusion transcripts in childhood acute leukemia. Int J Lab Hematol 2008, 30:286-291
11. Rowley JD: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining [letter]. Nature 1973, 243:290-293
12. Maurer J, Janssen JW, Thiel E, van Denderen J, Ludwig WD, Aydemir U: Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction. Lancet 1991, 337:1055-1058
13. Biernaux C, Loos M, Sels A, Huez G, Stryckmans P: Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. Blood 1995, 86:3118-3122
14. Bose S, Deininger M, Gora-Tybor J, Goldman JM, Melo JV: The presence of typical and atypical BCR-ABL fusion genes in leukocytes of healthy individuals: biologic significance and implications for the assessment of minimal residual disease. Blood 1998, 92:3362-3367 (Pubitemid 28492345)
15. Nakamura T, Mori T, Tada S, Krajewski W, Rozovskaia T, Wassell R, Dubois G, Mazo A, Croce CM, Canaani E: ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation. Mol Cell 2002, 10:1119-1128 (Pubitemid 35453829)
16. van Dongen JJ, Macintyre EA, Gabert JA, Delabesse E, Rossi V, Saglio G, Gottardi E, Rambaldi A, Dotti G, Griesinger F, Parreira A, Gameiro P, Diáz MG, Malec M, Langerak AW, San Miguel JF, Biondi A: Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: Investigation of minimal residual disease in acute leukemia. Leukemia 1999, 13:1901-1928
17. Biondi A, Rambaldi A, Rossi V, Elia L, Caslini C, Basso G, Battista R, Barbui T, Mandelli F, Masera G, Croce C, Canaani E, Cimino G: Detection of ALL-1/AF4 fusion transcript by reverse transcription-polymerase chain reaction for diagnosis and monitoring of acute leukemias with the t(4;11) translocation. Blood 1993, 82:2943-2947 (Pubitemid 23334917)
18. Biondi A, Cimino G, Pieters R, Pui CH: Biological and therapeutic aspects of infant leukemia. Blood 2000, 96:24-33 (Pubitemid 30456446)
19. Kim-Rouille MH, MacGregor A, Wiedemann LM, Greaves MF, Navarrete C: MLL-AF4 gene fusions in normal newborns. Blood 1999, 93:1107-1108
20. Basecke J, Cepek L, Mannhalter C, Krauter J, Hildenhagen S, Brittinger G, Trumper L, Griesinger F: Transcription of AML1/ETO in bone marrow and cord blood of individuals without acute myelogenous leukemia. Blood 2002, 100:2267-2268 (Pubitemid 35001270)
21. Wiemels JL, Xiao Z, Buffler PA, Maia AT, Ma X, Dicks BM, Smith MT, Zhang L, Feusner J, Wiencke J, Pritchard-Jones K, Kempski H, Greaves M: In utero origin of t(8;21) AML1-ETO translocations in childhood acute myeloid leukemia. Blood 2002, 99:3801-3805
22. Weisser M, Kern W, Schoch C, Hiddemann W, Haferlach T, Schnittger S: Risk assessment by monitoring expression levels of partial tandem duplications in the MLL gene in acute myeloid leukemia during therapy. Haematologica 2005, 90:881-889 (Pubitemid 41024890)
23. Dohner K, Tobis K, Ulrich R, Frohling S, Benner A, Schlenk RF, Döhner H: Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics: a study of the Acute Myeloid Leukemia Study Group Ulm. J Clin Oncol 2002, 20:3254-3261 (Pubitemid 34831523)
24. Steudel C, Wermke M, Schaich M, Schakel U, Illmer T, Ehninger G, Thiede C: Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia. Genes Chromosomes Cancer 2003, 37:237-251 (Pubitemid 36667562)
25. Weisser M, Haferlach T, Schoch C, Hiddemann W, Schnittger S: The use of housekeeping genes for real-time PCR-based quantification of fusion gene transcripts in acute myeloid leukemia. Leukemia 2004, 18:1551-1553 (Pubitemid 39264082)
26. Caligiuri MA, Strout MP, Lawrence D, Arthur DC, Baer MR, Yu F, Knuutila S, MRózek K, Oberkircher AR, Marcucci G, de la Chapelle A, Elonen E, Block AW, Rao PN, Herzig GP, Powell BL, Ruutu T, Schiffer CA, Bloomfield CD: Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics. Cancer Res 1998, 58:55-59 (Pubitemid 28027716)
27. Shiah HS, Kuo YY, Tang JL, Huang SY, Yao M, Tsay W, Chen YC, Wang CH, Shen MC, Lin DT, Lin KH, Tien HF: Clinical and biological implications of partial tandem duplication of the MLL gene in acute myeloid leukemia without chromosomal abnormalities at 11q23. Leukemia 2002, 16:196-202 (Pubitemid 34145136)
28. Whitman SP, Hackanson B, Liyanarachchi S, Liu S, Rush LJ, Maharry K, Margeson D, Davuluri R, Wen J, Witte T, Yu L, Liu C, Bloomfield CD, Marcucci G, Plass C, Caligiuri MA: DNA hypermethylation and epigenetic silencing of the tumor suppressor gene. SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplication Blood 2008, 112:2013-2016
29. Santamaria C, Carmen M, Fernandez C, Martin-Jimenez P, Balanzategui A, Sanz RG, San Miguel JF, and Gonzalez MG: Using quantification of the PML-RARA transcript to stratify the risk of relapse in patients with acute promyelocytic leukemia. 2007, 92:315-22
30. Doepfner KT, Boller D, Arcaro A: Targeting receptor tyrosine kinase signaling in acute myeloid leukemia. Crit Rev Oncol Hematol 2007, 63:215-230 (Pubitemid 47126864)